PMGC Holdings (ELAB) Net Shares Issued and Repurchased (2022 - 2025)
PMGC Holdings' (ELAB) quarterly Net Shares Issued and Repurchased came in at $3.0 in Q4 2025, down 99.26% year-over-year from $407.0 in Q4 2024, and down 93.02% quarter-over-quarter from $43.0 in Q1 2025.
Analysis
PMGC Holdings (ELAB) Net Shares Issued and Repurchased (2022 - 2025) Analysis & Trends
PMGC Holdings has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $3.0 for Q4 2025.
- In Q4 2025, Net Shares Issued and Repurchased fell 99.26% year-over-year to $3.0; the TTM figure through Dec 2025 stood at $3.0 (down 99.26% YoY), while the FY2025 annual figure was $3.0, down 99.26% from the prior year.
- Net Shares Issued and Repurchased came in at $3.0 for Q4 2025 at PMGC Holdings, down from $43.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $412000.0 in Q4 2022 to a low of $3.0 in Q4 2025.
- Average Net Shares Issued and Repurchased over 4 years is $101390.0, with a median of $40203.5 recorded in 2023.
- Year-over-year, Net Shares Issued and Repurchased sank 99.96% in 2023 and jumped 143.71% in 2024.
- Over 4 years, Net Shares Issued and Repurchased stood at $412000.0 in 2022, then slumped by 99.96% to $167.0 in 2023, then soared by 143.71% to $407.0 in 2024, then slumped by 99.26% to $3.0 in 2025.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $3.0 in Q4 2025, $43.0 in Q1 2025, and $407.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.09 Bn | 193.10 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.68 Bn | 176.50 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.79 Bn | 73.79 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.35 Bn | 48.21 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.40 Bn | 30.10 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.66 Bn | 30.38 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.14 Bn | 29.14 Bn | 1.16 Mn | - |
| 10 | PMGC Holdings | 2.25 Mn | -16.55 Mn | 385,691.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.00 |
| Mar 31, 2025 | 43.00 |
| Dec 31, 2024 | 407.00 |
| Mar 31, 2024 | 92,500.00 |
| Dec 31, 2023 | 167.00 |
| Jun 30, 2023 | 80,000.00 |
| Dec 31, 2022 | 412,000.00 |
| Sep 30, 2022 | 226,000.00 |